Susan Hasty, Publisher
Table of Contents . . . September 20th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Adverse Drug Effects - Combination therapy for chronic hepatitis C may cause pancreatitis
Chronic Hepatitis B - HBV-positive kidneys merit prudent use in HBV-infected transplant recipients
Hepatology - CD8-1 is a reporter substrate for cells that harbor hepatitis C replication
Oncogenesis - RBMY gene expression associates with male liver cancer formation
Transplant Medicine - Pre-emptive antivirals aid living donor liver transplant recipients
Antiretroviral Therapy - HAART improves course of hepatitis C virus infection in HIV coinfected patients
Antiviral Therapy - Suppressor of cytokine signaling proteins keep interferon from treating HCV
Autoimmune Disease - Interferons associate with the onset of thyroid dysfunction
Cancer Risk Factor - CD34-positive endothelial cells favor the risk for HBV-linked liver cancer
Cancer Therapy - p53 Status dictates how well eicosapentaenoic acid destroys liver cancer
Chronic Hepatitis C - Interferon-alpha is a safe therapy for liver transplant patients
Clinical Trials - Phase 2a trials reopened as U.S. FDA, pharmaceutical company reach agreement
Coronavirus - Structural basis proposed for coronavirus-mediated membrane fusion
Correctional Health - Organized healthcare delivery in Texas prison system improves health outcomes
Cytomegalovirus - Necrotizing enterocolitis with atypical features may signal infant CMV infection
Disease Associations - Many factors sway the onset of extrahepatic disorders in chronic hepatitis C
Drug Development - Pharmaceuticals get U.S. government grant to evaluate hepatitis C drug in Russia
Gastroenterology - Contrast agents improve ultrasound's ability to detect liver cancer
HIV Coinfection - HIV-HTLV-I/II coinfection increases risk of clinical complications
Hepatitis B Vaccine - Postvaccination hepatitis B surface antigenemia explored
Hepatitis B Virus - Clevudine potent and tolerable in hepatitis B virus-infected patients
Hepatitis C Vaccine - Hepatitis C virus mutation affects proteasomal epitope processing
Hepatitis C Virus - Glycoprotein E2 has mechanistic features in common with class II fusion proteins
Hepatitis C Virus - HCV coinfection associated with higher risk of diabetes in HAART era
Hepatitis C Virus - Hepatitis C virus infection associated with increased risk of malignant lymphoma
Hepatitis C Virus - Peginterferon and ribavirin safe/effective in HCV-infected methadone patients
Hepatitis C Virus - Reported HCV cases up statewide in Wisconsin
Hepatitis C Virus Therapy - Interferon-alpha battles hepatitis C replication on several fronts
Hepatitis Vaccine - Anti-hepatitis A immune response found in renal transplant patients
Hepatitis Vaccine - HIV-infected patients should receive hepatitis B vaccination
Hepatocellular Carcinoma - MAGE-n peptide could be immunotherapy target
Immunology - Cytokine mutations associate with recurrent HCV after liver transplantation
Immunology - Natural killer cell interactions govern immunity to hepatitis C virus
Immunology - Peripheral CD4+CD8+ T cells participate in adaptive immunity
Liver Cancer - Identifying gene expression patterns may provide markers for diagnostic purposes
Obstetrics - Hepatitis E outbreak could cause maternal deaths to skyrocket in Sudan
Occupational Health - 2-Methoxy ethanol does not harm the livers of exposed workers
Oncogenesis - Hepatitis C virus infection may cause intrahepatic cholangiocarcinoma
Transplant Medicine - Cyclosporine A and PI interactions in liver transplantation can be managed
Viral Genomics and Genetics - Divergent hepatitis B virus genotypes in Poland reflect migratory events
Viral Genomics and Genetics - Hepatitis C virus genotype 1b variants bear changes in replication
Virology - Wild-type protein interferes with the replication of HCV adapted replicons
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.